Janus Henderson Group PLC Mirum Pharmaceuticals, Inc. Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 5,236,277 shares of MIRM stock, worth $376 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
5,236,277
Previous 4,766,109
9.86%
Holding current value
$376 Million
Previous $215 Million
24.11%
% of portfolio
0.14%
Previous 0.12%
Shares
10 transactions
Others Institutions Holding MIRM
# of Institutions
230Shares Held
56.1MCall Options Held
25.3KPut Options Held
98.9K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$488 Million18.24% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$232 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.76MShares$198 Million5.52% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$189 Million2.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.56MShares$184 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.64B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...